Evidence map›Paper›PMID 26798416›Full record

ReviewOxidative medicine and cellular longevity2016

Role of Natural Stilbenes in the Prevention of Cancer.

J Antoni Sirerol, María L Rodríguez, Salvador Mena, Miguel A Asensi, José M Estrela, Angel L Ortega

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 1 synthesis or guideline pooled it, 213 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Stilbenes from Vine Extracts: Therapeutic Potential and Mechanisms.International journal of molecular sciences · 2025
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

J Antoni SirerolDepartment of Physiology, Faculty of Pharmacy, University of Valencia, Avenida Vicente Andrés Estellés s/n, Burjassot 46100, Valencia, Spain.
María L RodríguezDepartment of Physiology, Faculty of Pharmacy, University of Valencia, Avenida Vicente Andrés Estellés s/n, Burjassot 46100, Valencia, Spain.
Salvador MenaDepartment of Physiology, Faculty of Pharmacy, University of Valencia, Avenida Vicente Andrés Estellés s/n, Burjassot 46100, Valencia, Spain.
Miguel A AsensiDepartment of Physiology, Faculty of Pharmacy, University of Valencia, Avenida Vicente Andrés Estellés s/n, Burjassot 46100, Valencia, Spain.
José M EstrelaDepartment of Physiology, Faculty of Pharmacy, University of Valencia, Avenida Vicente Andrés Estellés s/n, Burjassot 46100, Valencia, Spain.
Angel L OrtegaDepartment of Physiology, Faculty of Pharmacy, University of Valencia, Avenida Vicente Andrés Estellés s/n, Burjassot 46100, Valencia, Spain.
Universitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural stilbenes are an important group of nonflavonoid phytochemicals of polyphenolic structure characterized by the presence of a 1,2-diphenylethylene nucleus. Stilbenes have an extraordinary potential for the prevention and treatment of different diseases, including cancer, due to their antioxidant, cell death activation, and anti-inflammatory properties which associate with low toxicity under in vivo conditions. This review aims to discuss various approaches related to their mechanisms of action, pharmacological activities in animal models and humans, and potential chemoprevention in clinical studies. The biological activity of natural stilbenes is still incompletely understood. Furthermore, after administration to animals or humans, these molecules are rapidly metabolized. Thus pharmacokinetics and/or activities of the natural structures and their metabolites may be very different. Novel drug formulations have been postulated in order to improve stability and bioavailability, to minimize side effects, and to facilitate interaction with their domains in target proteins. These pharmacological improvements should lead stilbenes to become effective candidates as anticancer drugs.

Indexed as

ChemopreventionAnimalsClinical Trials as TopicHumansNeoplasmsResveratrolStilbenesStructure-Activity RelationshipResveratrolStilbenes

Identifiers

PMID26798416
PMCPMC4698548
OpenAlexW2261519740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.